Taiwania Capital is a venture capital firm that establishes partnership with worldwide companies and to boost Taiwan’s economic growth.
Business Model:
Revenue: $0
Employees: 0-0
Address: 3945 Freedom Circle Suite 760
City: Santa Clara
State: CA
Zip: 95054
Country: US
Taiwania Capital is a venture capital firm that establishes partnership with worldwide companies and to boost Taiwan’s economic growth.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2022 | Regenacy Pharmaceuticals | Series B | 0 |
3/2020 | Regenacy Pharmaceuticals | Series A | - |
8/2021 | AEye | Post-IPO Equity | 0 |
3/2023 | Genialis | Series A | 0 |
5/2023 | Ethernovia | Series A | 0 |
1/2022 | Pavilion Data Systems, Inc. | Series D | 0 |
1/2023 | Photoneo Brightpick Group | Series B | 0 |
6/2023 | Sensoneo | Series A | 0 |
5/2022 | Avesha | Funding Round | - |
3/2021 | Ubiik | Series A | 5M |
1/2021 | Tripresso | Series A | - |
5/2020 | EirGenix | Post-IPO Equity | - |
8/2020 | Fractyl Health | Series E | 0 |
10/2018 | EirGenix | Post-IPO Equity | - |
5/2019 | Ambiq Micro | Convertible Note | - |
8/2022 | AIxMed | Series A | - |
8/2022 | Bigfoot Biomedical | Convertible Note | - |
8/2022 | FaceHeart Corporation | Series A | - |
8/2022 | Cognito Health | Convertible Note | - |
8/2018 | Cognito Health | Series A | - |
1/2020 | Oculii | Series A | - |
6/2020 | C4 Therapeutics | Series B | 150M |
8/2022 | AmMax | Series A | - |
5/2019 | Tricorntech | Series D | - |
8/2022 | SyneuRx International Taiwan Corp. | Post-IPO Equity | - |
5/2020 | Pavilion Data Systems, Inc. | Convertible Note | - |
1/2019 | Frequency Therapeutics | Series B | - |
1/2020 | Oculii | Convertible Note | - |
5/2021 | Oculii | Series B | 0 |
5/2018 | Ambiq Micro | Series E | - |
7/2019 | Frequency Therapeutics | Series C | 0 |
3/2021 | Suono Bio | Series A | 0 |
8/2022 | URSROBOT INC | Series A | - |
4/2021 | Touché Solutions | Venture Round | - |
6/2021 | FIGUR8 | Series A | 0 |
8/2022 | PharmaEssentia | Post-IPO Equity | - |
8/2022 | EirGenix | Post-IPO Equity | - |
8/2022 | TFBS Bioscience | Series B | - |
8/2022 | Aesop Technology | Seed Round | 3M |
1/2021 | Avesha | Seed Round | 0 |
6/2021 | Cognito Health | Convertible Note | - |
1/2023 | Oxipit | Venture Round | 4.9M |
8/2022 | Point Robotics Medtech | Series A | 18M |
11/2022 | Litilit | Venture Round | 3.5M |
8/2021 | SafeLiShare | Seed Round | 0 |
10/2021 | Ethernovia | Series A | - |
11/2020 | Viracta Therapeutics | Series E | 0 |
7/2022 | Aesop Technology | Series A | 0 |
4/2022 | Verana Networks | Series B | 0 |
4/2022 | Nanolive | Series C | 0 |
1/2022 | Windgap Medical | Series B | 0 |
2/2020 | DSP Concepts | Series B | 14.5M |
12/2022 | Artilux Inc. | Convertible Note | - |
11/2022 | 3NETS | Seed Round | 11M |
11/2021 | ARRIS | Series C | 88.5M |
8/2022 | C4 Therapeutics | Post-IPO Equity | - |
8/2022 | Fractyl Health | Series F | - |
11/2021 | Landing AI | Series A | 0 |
10/2022 | DataPelago | Series A | - |
3/2022 | Light Field Lab | Funding Round | - |
11/2020 | Dcard | Series C | - |
8/2019 | Light Field Lab | Series A | 28M |
8/2022 | Frequency Therapeutics | Post-IPO Equity | - |
8/2022 | Xgene Pharmaceutical | Series B | - |
10/2019 | Viracta Therapeutics | Series D | - |
5/2019 | Touché Solutions | Series A | 4M |
1/2020 | Tripresso | Series A | - |
9/2020 | Artilux Inc. | Series B | - |
8/2021 | Elixiron Immunotherapeutics | Series A | 0 |
11/2018 | AEye | Series B | 40M |
2/2023 | Light Field Lab | Series B | 0 |
10/2020 | Ambiq Micro | Series F | 127.3M |
12/2021 | Appaegis | Seed Round | - |
1/2021 | AEye | Convertible Note | - |
7/2021 | Kdan Mobile Software | Series B | 0 |
3/2020 | Landing AI | Convertible Note | - |
4/2022 | FIGUR8 | Convertible Note | - |
3/2020 | Ambiq Micro | Convertible Note | - |
3/2020 | Metanoia Communications | Venture Round | 19.3M |
9/2022 | Nanolive | Series C | 2.2M |
8/2022 | Health2Sync | Series B | - |
11/2021 | Pavilion Data Systems, Inc. | Series C | - |
8/2019 | Pavilion Data Systems, Inc. | Series C | 0 |
3/2022 | Canner | Seed Round | 0 |
3/2020 | AEye | Convertible Note | - |
4/2020 | ARRIS | Series B | 48.5M |
7/2022 | Aesop Technology | Series A | 0 |
4/2022 | Verana Networks | Series B | 0 |
4/2022 | Nanolive | Series C | 0 |
3/2022 | Canner | Seed Round | 0 |
1/2022 | Windgap Medical | Series B | 0 |
1/2022 | Pavilion Data Systems, Inc. | Series D | 0 |
12/2021 | Appaegis | Seed Round | 0 |
11/2021 | Landing AI | Series A | 0 |
8/2021 | Elixiron Immunotherapeutics | Series A | 0 |
8/2021 | AEye | Post-IPO Equity | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|